Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel
Status:
Withdrawn
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to explore the safety and tolerability of AZD0530 in
combination with carboplatin and paclitaxel in Japanese patients with non small cell lung
cancer and epithelial ovarian cancer.